Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This randomized controlled trial aims at evaluating the efficacy and safety of the antidiabetics metformin versus empagliflozin on chronic kidney disease (CKD) progression in patients with CKD stages 2 or/and 3.
Epistemonikos ID: 41b7ea1f0c0ac863ddd94f6e035ed98618fa789a
First added on: Dec 20, 2022